Document Detail

Reconsidering brain death: a lesson from Japan's fifteen years of experience.
MedLine Citation:
PMID:  12945466     Owner:  NLM     Status:  MEDLINE    
Japan has been holding a nationwide debate over the nature of death for nearly twenty years. That debate led eventually to a law that gives citizens the opportunity to choose which of two views of death will apply to their own death. That law is now up for revision, and the debate is reving up.
M Morioka
Related Documents :
17284476 - Relationship of neonatologists' end-of-life decisions to their personal fear of death.
23064306 - Spontaneous intestinal perforation.
21133966 - Does in utero exposure to synthetic glucocorticoids influence birthweight, head circumf...
16704816 - 1951 influenza epidemic, england and wales, canada, and the united states.
24246596 - Transient tachypnea of the newborn: is empiric antimicrobial therapy needed?
19171576 - Skeletal surveys in infants with isolated skull fractures.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Hastings Center report     Volume:  31     ISSN:  0093-0334     ISO Abbreviation:  Hastings Cent Rep     Publication Date:    2001 Jul-Aug
Date Detail:
Created Date:  2003-08-29     Completed Date:  2003-09-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0410447     Medline TA:  Hastings Cent Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  41-6     Citation Subset:  E; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Attitude to Death*
Brain Death / legislation & jurisprudence*
Health Policy / legislation & jurisprudence*
Organ Transplantation / legislation & jurisprudence
Patient Participation / legislation & jurisprudence*
Tissue Donors / legislation & jurisprudence*
Tissue and Organ Harvesting / legislation & jurisprudence*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Between subway and spaceship: practical ethics at the outset of the twenty-first century.
Next Document:  An analysis of first authorizations for lipid-lowering drugs in Belgium.